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While acute infections cause short-term tissue damage, their long-term impact remains unknown. In a recent
publication in Cell, Morais da Fonseca et al. (2015) demonstrate disruption of mesenteric lymph nodes and
associated lymphatics after Yersinia pseudotuberculosis infection and clearance. This leads to chronic
inflammation and an inability to initiate subsequent intestinal immune responses.When faced with an infection, the immune
system activates a number of systems to
clear the invader. This defense needs to
be strong enough to rapidly clear the
infection, while simultaneously limiting
collateral damage to the tissue. Once
the intruder is eliminated, tissue order
is restored through mechanisms that
resolve inflammation, repair tissue struc-
ture, and reestablish tissue functionality.
Chronic conditions exhibit many of the
same immune signatures of acute infec-
tion, including loss of barrier function, tis-
sue destruction, and functional impair-
ment, and are becoming increasingly
prevalent worldwide (Karin et al., 2006).
In many cases, there is speculation that
an infectious agent may cause these
chronic diseases; however, in most cases
the etiology remains unknown. In cases in
which the infectious agent is known, like in
Helicobacter pylori infection, the agent is
not cleared (Franceschi et al., 2014; Karin
et al., 2006), whereas in others, like in
lyme disease, problems persist after
treatment of infection (Koedel et al.,
2015). Nonetheless, there is little direct
evidence for a common mechanism by
which acute infections impact immune
cell-regulated tissue homeostasis and
the development of chronic disease.
Proof of such amechanismwould provide
a framework to develop therapeutic stra-
tegies to resolve a number of chronic
diseases.
Using Yesrsinia pseudotuberculosis as
a model of gastrointestinal infection, Mor-
ais da Fonseca et al. (2015) demonstrate
that acute infection can have a dramatic
and long-lasting impact on the structure
and function of the intestinal immune sys-
tem, resulting in chronic inflammation ofthe local tissue as well as the inability to
respond to new challenges (Figure 1).
Their data provide evidence for a
direct link between acute infections and
the development of chronic inflammatory
disease.
Despite clearance of Yersinia from the
mesenteric lymph nodes (MLN) and
normal resolution of inflammation in other
organs, Morais da Fonseca et al. (2015)
found chronic mesenteric lymphadenop-
athy (CL+) 4 weeks post-infection in a
subset of infected mice. This observation
resembled similar features of the MLN
pathology found in humans infected
with Yersinia (Asano, 2012). Assessment
of cell composition revealed increased
numbers of infiltrating monocytes and
neutrophils in the mesenteric lymph
node after bacterial clearance. In addi-
tion, neutrophil levels remained high
for 9 months post-infection. Alongside
this increased infiltration of inflammatory
cells, the authors found significantly
increased intestinal bacteria in the MLN
of CL+ mice.
To determine whether this extended
MLN inflammation impacted the induction
of subsequent immune responses, Mor-
ais da Fonseca et al. (2015) compared
induction of oral tolerance in naive mice
and mice that cleared Yersinia infection
with (CL+) or without (CL) lymphade-
nopathy. While there was no difference
in the induction of oral tolerance in naive
or CL mice, CL+ mice showed a signifi-
cant defect in the ability to induce immu-
nosuppressive T regulatory cell (Treg)
responses to oral antigens. CL+ mice
also had reduced responsiveness to oral
vaccination. Alongside this reduced in-
duction of intestinal immunity, the authorsCell Host & Microbe 18found that the migratory conventional
CD103+CD11b+ dendritic cell (DC) popu-
lation was almost completely absent
from the MLN.
Morais da Fonseca et al. (2015) hypoth-
esized that in addition to the severe struc-
tural damage to the MLN, there were
additional insults inhibiting DC trafficking
through the lymphatics to the MLN. As
the lymphatics also transport lipids, they
were able to use a fluorescent long-chain
fatty acid, Bodipy FL C16, to assay for
structural integrity of the lymphatics. The
authors found significant Bodipy leakage
into the mesenteric adipose tissue (MAT)
in CL+ animals, demonstrating loss of
lymphatic containment between the in-
testine and MLN in CL+ animals. Surpris-
ingly, this defect in lymphatic containment
persisted upward of 42 weeks post clear-
ance of infection. Interestingly, Morais da
Fonseca et al. (2015) observed similar
lymphatic leakage into the MAT in the
acute phase of mouse models of colitis
initiated by T cell transfer as well as infec-
tion with the parasite Toxoplasma gondii.
Additionally, the loss of lymphatic integrity
resulted in massive cellular infiltration into
the MAT, including increased neutrophil
and macrophage populations as well as
CD103+CD11b+DCs. This shifted cellu-
larity corresponded to a shift from Type
2 to Type1 immunity.
Finally, as intestinal microbes are
thought to potentiate inflammation in
other models of immune dysregulation
(Round and Mazmanian, 2009), Morais
da Fonseca et al. (2015) tested the impact
of the microbiota on immune disruption
after Yersinia infection. Using Germ-free
animals as well as antibiotic treatment,
they found that Yersinia infection still, October 14, 2015 ª2015 Elsevier Inc. 383
Figure 1. Damage from Acute Yersinia pseudotuberculosis Infection Has Long-Term Impacts on the Structure and Function of the Intestinal
Immune System
Under homeostatic conditions, the mesenteric associated fat has a Type 2 immune profile and CD103+CD11b+ DCs migrate from the intestine to the mesenteric
lymph node (MLN, left). After acute infection with Yersinia pseudotuberculosis, there are extensive structural changes to the MLN, including formation of ab-
scesses and accumulation of neutrophils (right). In parallel, there is leakage of the lymphatics into the mesenteric adipose tissue (MAT). MAT Type 1 immunity is
driven by accumulation of microbes and increased neutrophils and M1 macrophages. CD103+CD11b+ DCs are shunted into the MAT and away from the MLN.
These changes result in loss of intestinal immune priming.
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leakage post-infection in the absence of
intestinal microbes. However, antibiotic
treatment did reduce Type 1 inflammation
in the MAT and neutrophil infiltration.
Germ-free animals as well as antibiotic
treatment also restored normal homing
of CD103+ CD11b+ DCs to the MLN and
reduced their accumulation in the MAT.
Importantly, antibiotic treatment also
restored the efficacy of oral vaccination
in CL+ mice.
The symptoms of infectious diseases
can be either due to direct damage to
the host inflicted by the pathogen, or
due to immunopathology—the collateral
damage to the host tissues caused by
the immune response. The functional re-
covery of homeostasis after an inflamma-
tory injury requires tissue repair and rees-
tablishment of tissue functionality. The
sustained damage to the lymphatic ves-384 Cell Host & Microbe 18, October 14, 201sels after clearance of Yersinia infection
brings to question the long-term effects
of acute infection on tissue repair. Why
is lymphatic vessel tissue damage not
resolved after Yersinia infection? And
does such long-term damage occur after
other acute intestinal infections? As Mor-
ais da Fonseca et al. (2015) show leakage
in Toxoplasma gondii infection, it would
be important to determine whether the
damage to the lymphatics is resolved af-
ter clearance of Toxoplasma.
Together, Morais da Fonseca et al.
(2015) have demonstrated that infection-
mediated disruption of tissue barrier sites
can result in long-term increases in tissue
inflammation as well as defects in induc-
tion of new immune responses. These
findings offer an interesting model for
thinking about pathology in other chronic
inflammatory diseases such as inflamma-
tory bowel disease and obesity. While an5 ª2015 Elsevier Inc.infectious insult is not known, changes in
MAT (creeping fat), including Type 1 in-
flammatory shifts, have long been associ-
ated with disease activity in Crohn’s
disease patients (Fink et al., 2012).
Furthermore, alterations in microbial
pattern recognition receptors are recog-
nized as risk factors in the development
of Crohn’s disease and are expressed in
MAT. In a parallel manner, changes in ad-
ipose tissue inflammatory status during
obesity are thought to result from induc-
tion of a TLR-mediated-Type 1 inflamma-
tory response to microbial products in
adipocytes and immune cells (Caesar
et al., 2015). As seen in the studies by
Morais da Fonseca et al. (2015), acute
infection-regulated destruction of tissue
barriers in these disease settings could
result in detrimental responses of adipose
tissue to microbial molecules. Future
studies should also identify whether there
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damage and how this is perturbed by
acute infections.REFERENCES
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The role of gut bacteria in modulating gastrointestinal physiology is increasingly being appreciated. In a
recent issue ofCell, Dey et al. (2015) report how a single dietary ingredient—turmeric—interacts with gut bac-
teria to alter gastrointestinal motility.Gastrointestinal (GI) motility enables mix-
ing, storage, anterograde propulsion and
absorption of nutrients, and represents
one of the most important functions of
the GI tract. GI transit time, the time for a
food bolus to pass through the GI tract,
is often used as a surrogate for GI motility.
This seemingly simple process requires
coordination among several key cell types
in the enteric neuromuscular apparatus,
including the enteric neurons and glia,
interstitial cells of Cajal (ICC), smooth
muscle, and immune cells. Until recently,
the majority of the work on GI motility dis-
orders has focused on the interplay
among different host cell types, even
though it is established that gut bacteria
and luminal compounds have a significant
impact on GI motility. However, recent
studies have started to uncover this addi-
tional layer of complexity, exploring how
gut microbiota and their products influ-
ence host GI physiology.
Studies of gut microbiota and neuro-
muscular apparatus, including neuro-
transmitters in the context of GI motility,
have shown that gut microbiota and their
products have effects on the enteric neu-
rons, enteric muscularis macrophages,
and enteric glia. Gut microbiota-derivedlipopolysaccharide (LPS) improves en-
teric neuronal survival and influences GI
motility (Figure 1), acting via the TLR4
and NF-kB pathway (Anitha et al., 2012).
Gut microbiota products also influence
the crosstalk between enteric neurons
and muscularis macrophages (Figure 1),
which plays an important role in maintain-
ing normal GI motility (Muller et al., 2014).
Serotonin, an important neurotransmitter
in the gut that plays a role in modulating
GI motility, can be modulated by gut mi-
crobes (Reigstad et al., 2015). Metabo-
lites resulting from primary and secondary
fermentation of dietary nutrients by gut
microbes, such as short-chain fatty acids
and bile acids (Figure 1), can increase se-
rotonin biosynthesis and release in the
gut, thereby altering GI motility in a diet-
dependent manner (Kashyap et al., 2013).
The new study by Dey et al. (2015) pro-
vides an in-depth investigation of the
interaction between diet and gut micro-
biota to elucidate the mechanisms by
which these interactions influence GI
motility. Travelers’ diarrhea is common
during travel to the developing world and
is often attributed to acquisition of patho-
genic bacteria or viruses. However, an
additional aspect of travel is short-termexposure to new diets. Diet is a dominant
factor in shaping gut microbial commu-
nities (Wu et al., 2011) and has been
shown to influenceGImotility in both ami-
crobiota-dependent and independent
manner (Kashyap et al., 2013). In a series
of elegant experiments, the authors
subject gnotobiotic mice, colonized with
microbiota from healthy human donors
(humanized) from across the world, to
multiple cycles of short-term dietary inter-
ventions, representing native and non-
native diets. The authors were able to
identify several bacterial taxa present in
different groups of humanized mice that
have diet-dependent effects on GI transit.
Some of these taxa (e.g., E. desmolans)
had opposite correlations with transit
time depending on supplementation with
native or non-native diet. As expected,
diet also showed effects on gut micro-
biota that did not correlate with GI transit
time.
In order to investigate bacterial media-
tors of the dietary effects on GI transit,
Dey et al. (2015) quantified bile acid me-
tabolites in the stool. They found that
faster transit time was associated with
an increase in unconjugated bile acids, re-
sulting from the activity of bacterial bile, October 14, 2015 ª2015 Elsevier Inc. 385
